PitchBook News - VC returns data and new exit strategies

Also: A guide to ~500 healthcare managers and their performance; New ideas needed to solve mass transportation issues; Q2 Enterprise SaaS Report...
Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Research Pitch
August 31, 2024
Healthcare checkup: PE healthcare specialists are outraising the broader asset class, but the story is different in VC. Our report is a guide to ~500 healthcare managers and their performance. Read it here.

Join our team! We're hiring a private capital analyst in our Singapore office to cover PE and VC in Asia-Pacific. We'd love for you to read the job description and/or share it with your networks: click here.
 
Analyzing VC returns by series and alternative exit strategies
The risk-reward tradeoff in VC should compensate seed investors to a relatively higher degree than, say, Series D investors. And it does.

If seed investments didn't generate outsized returns, few investors would finance young startups.

Our returns-by-series model highlights the return differences between investment stages. Seed, which we have added to the model, vastly outperforms other series investments, bringing home an annualized return of 25.5%.
 
Click for our latest on VC returns by series.

But these historical market returns are currently under significant strain. The lack of exits has cratered distributions, and valuation pressures are expected to compress future returns.

Later-series deals have been hit particularly hard. Not only are those returns relatively lower on an annualized basis, but the timelines of exits have extended significantly.

As IPOs and M&A remain elusive, many investors have turned to alternative forms of return generation.

Secondary exchanges have been around for some time, but until recently, there haven't been sufficient tailwinds to propel their wider adoption.

The recent uptick of investor interest in VC secondaries has led to record fundraising for this liquidity strategy. Several firms have also launched continuation funds, searching for ways to clean up their aging portfolios.

For investors across the venture lifecycle, the realization of returns is what truly matters. Though discounts may be given to create the needed liquidity, at some point, cementing a slightly lower-than-expected annualized return is better than seeing outsized paper gains disappear.

For more data and analysis, read the free research from our VC team this week:

VC Returns by Series: Part IV

Exit Alternatives for US VC
 
Best,

Emily Zheng
Senior Analyst, Venture Capital
Share: Email LinkedIn Twitter Facebook
A high bar for exits hits biopharma startups
Biopharma remains a robust sector for VC investment, showing resilience despite a challenging exit environment.

Recent data highlights a sharp decline in exit value, which dropped from $10 billion in Q1 to $4.5 billion in Q2. This underscores a shift in investor focus, where only biopharma companies with strong clinical data are successfully navigating IPOs.

As a result, many startups—particularly those innovating in areas such as gene editing, targeted cancer therapies, and AI-driven drug discovery—face prolonged development timelines without immediate prospects for acquisition or entry into public markets.

Additionally, the forthcoming BIOSECURE Act may significantly impact the biopharma landscape by restricting collaborations with certain Chinese firms by 2032, potentially driving US companies toward local contract research organizations.

AI remains a key area of VC activity, with significant raises by companies that may see consolidation. Investments in emerging technologies like CRISPR and oncolytic virus therapies continue to be strong. The obesity treatment sector is also attracting new entrants, challenging established pharmaceutical leaders.

Looking ahead, deal activity is expected to remain stable through late 2024, though challenges in achieving exits—particularly via public markets and M&A—are likely to persist, especially if interest rates remain elevated.

Read a preview of our Biopharma Report
 
Best,

Kazi Helal, Ph.D.
Senior Analyst, Emerging Technology
Share: Email LinkedIn Twitter Facebook
 
A message from PitchBook Data  
2024 advertising opportunities with PitchBook
Clients trust PitchBook Media for top-tier ad placements in our seven specialized newsletters that connect with 2.1 million highly engaged PE and VC professionals. Backed by our robust global market data, we craft custom research reports and amplify clients' existing thought leadership through partnerships on PitchBook's asset class reports or native sponsored content columns.

Explore our Media Kit for more information or email us at mediasales@pitchbook.com.
Share: Email LinkedIn Twitter Facebook
 
Market Updates  

US Public PE and GP Deal Roundup

Deals that target GPs are on a record pace.

A total of 89 have been announced or completed through July, an 84% increase YoY and on track to easily surpass the high mark of 114 deals in 2021.
 

Our report also focuses on financial and strategic trends involving the seven largest US-listed alternative managers, where fundraising is up 44% over 2023 across all strategies, driven primarily by private credit:

Read the free report
 
 
Thematic Research  

Micro-Mass Transit

Emissions and congestion are getting worse. Mass transit costs too much while serving too few.

One startup, Glydways, is taking a novel approach to mobility that is accessible, green, and capital-effective.

Our new research explains why overcoming the hurdles of urban transportation might require shedding traditional assumptions and embracing different thinking:

Read the free research
 
 
Industry & Tech Research  

Enterprise SaaS Report

VC funding in enterprise SaaS bounced back in Q2 as companies made inroads in human-like AI development.

Startups raised $22 billion across 713 deals, representing the sector's highest quarterly deal value in over a year—even when excluding xAI's massive round.

Our new report also dives into the world of emotion AI and tech that can analyze human features like facial expressions and speech patterns:

Read a free preview

 
Webinars & Events  

A reminder of upcoming events:

Sept. 9-11: We'd love to meet you at IPEM in Paris, an event for PE dealmakers that will feature 6,000 attendees representing 2,000+ firms, including 1,200 LPs and 1,000 GPs. We're also sponsoring the Private Debt Summit during the conference. More details here.

Sept. 11-12: Join us at the BVCA Summit in London, an event for private capital fund managers, institutional investors, pension funds, and family offices. LPs can register here; GPs and others can request to register.

Sept. 17: Our Tech Talks series continues with HydroX AI founder Zhuo Li on security, privacy, and copyright issues related to large language models. Register here.

Nov. 5-8: Come see us at SuperInvestor 2024 in Monaco. The event will feature 1,000+ senior LPs and 1,500+ GPs, offering more opportunities than ever to make industry connections. Register here.
 
 
In the News  

Our insights and data featured in the press:
  • Identifying sectors on the rise in climate tech. [WSJ]

  • The 12 biggest take-private PE acquisitions so far this year in tech. [TechCrunch]

  • Medical device companies are teaming up, providing evidence of further consumerization of healthcare, particularly in diabetes. [MedCity News]

  • Digging into PE's new access to the NFL. [Pensions & Investments]
If you're a journalist interested in interviewing our analysts or requesting data, contact our PR team.
 
 
ICYMI  

More of our recent research (* - report preview):

Market updates
Thematic research
Industry & tech research
Coming next week (subject to change)
  • Global Markets Snapshot: August
  • UK Private Capital Breakdown
  • Germany Market Snapshot
  • Insurtech Report*
  • Crypto Funds Note
 

Thanks for reading! Feel free to email us any time with feedback, questions, or tips!

Learn more about the PitchBook Institutional Research Group, meet our analysts, or access our research libraries for clients and non-clients.

Did someone forward this newsletter to you? Sign up at pitchbook.com/subscribe.
 
 
Since yesterday, the PitchBook Platform added:
7
VC valuations
1609
People
618
Companies
41
Funds
See what our data software can do
 
About PitchBook | Terms of use | Advertise with us | Contact
Follow us: in twtr fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

PitchBook Data Inc., 901 Fifth Avenue, Suite 1200, Seattle WA 98164, United States

© 2024 PitchBook. Win what's next. All rights reserved.

Older messages

Crypto settlement signals an SEC shift

Friday, August 30, 2024

Navigating the VC liquidity drought; AI startup Codeium captures $1B+ valuation; how VC could curb a US transportation problem Don't want to receive these emails? Manage your subscription. Log in

Checking up on healthcare funds

Thursday, August 29, 2024

Entertainment investor forges into private credit; VC funds struggle for a foothold; how one smaller endowment trumped the Ivys Don't want to receive these emails? Manage your subscription. Log in

Sizing up VC returns by series

Wednesday, August 28, 2024

Charting gaming's next big hitmakers; VC drives the future of freight tech; NFL's new PE rules benefit a select few firms Don't want to receive these emails? Manage your subscription. Log

Enterprise SaaS springs back

Tuesday, August 27, 2024

Magnetar launches $235M AI fund; ranking VCs top fund families; how crypto can boost AI startups; private credit fund targets aging aircraft Don't want to receive these emails? Manage your

A rebound for retail fintech

Monday, August 26, 2024

Sunnier days for fund performance; Europe's startups face longer gaps between funding rounds; how do Europe's mega-funds stack up? Don't want to receive these emails? Manage your

You Might Also Like

The best books about AI&ML, 2024 edition

Saturday, December 21, 2024

For Your Holiday Reading ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

How to control your audience

Saturday, December 21, 2024

And turn them into raving fan-customers ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

$166K MRR - simple employee scheduling tool..

Saturday, December 21, 2024

+ What do you think? ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Your SaaS New Year’s Resolutions for 2025

Saturday, December 21, 2024

Here are Your Top 10 New Year's SaaS Resolutions To view this email as a web page, click here saastr daily newsletter Your SaaS New Year's Resolutions for 2025 By Jason Lemkin Thursday,

Presence Over Pressure: Leading with Confidence in Chaos

Saturday, December 21, 2024

We spoke with Jon Giesbrecht, the Director of Mental Performance and Player Development for the Vancouver Bandits, about how mindfulness and emotional regulation elevate performance in basketball,

Our full 2025 outlooks

Saturday, December 21, 2024

Also: Understanding the ins and outs of benchmarking; Where top-performing VCs place their early-stage bets; Read our latest emerging tech reports... Read online | Don't want to receive these

Piggybacking tweak to earn a ROI

Saturday, December 21, 2024

Inro, Qolaba, MySEOAuditor, ContentRadar, and SEO Pilot are still available til end of this week. Then, they're gone!! Get these lifetime deals now! (https://www.rockethub.com/) Today's hack

RIP Seedscout

Friday, December 20, 2024

Some Quick Hits From The Week ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

🔍 Boost ROI with Micro-Influencers

Friday, December 20, 2024

December 20, 2024 Hey, it's Alex here. We've talked about this before. But, it's worth repeating. You've learned from Olipop's story. 2B+ impressions on TikTok. How? Micro-

3-Day Old Side Hustle + Google Ranking System Exposed!

Friday, December 20, 2024

If you have been following me on Niche Pursuits for the last 10+ years, you'll know that I love side hustles! I love starting and testing new little projects. In fact, that why in every segment of